The Oncosearch | Oncotarget

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study Research Paper

Sarina A. Piha-Paul, Matthew H. Taylor, Daniel Spitz, Lee Schwartzberg, J. Thaddeus Beck, Todd M. Bauer, Funda Meric-Bernstam, Das Purkayastha, Linda Karpiak, Sebastian Szpakowski, Fadi Braiteh

Published Nov 5, 2019 · Vol. 10, No. 60 · pp. 6526-6535

Keywords: phosphatidylinositol 3-kinase pathway, buparlisib, advanced malignancies, molecular selection, tissue agnostic

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases Research Paper

Gozde Uzunalli, Alexandra M. Dieterly, Chinyere M. Kemet, Hsin-Yi Weng, Arvin H. Soepriatna, Craig J. Goergen, Aparna B. Shinde, Michael K. Wendt, L. Tiffany Lyle

Published Oct 29, 2019 · Vol. 10, No. 59 · pp. 6334-6348

Keywords: blood-brain barrier, blood-tumor barrier, non-small cell lung cancer, brain metastasis, aquaporin-4

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations Research Paper

Jun Gong, Edik M. Blais, Joseph R. Bender, Michelle Guan, Veronica Placencio-Hickok, Emanuel F. Petricoin, Michael J. Pishvaian, Gary Gregory, Richard Tuli, Andrew E. Hendifar

Published Oct 22, 2019 · Vol. 10, No. 58 · pp. 6260-6268

Keywords: pancreatic neuroendocrine tumors, genomic profiling, proteomic profiling, molecular pathways, co-occurring alterations

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Athira Narayan, Yu Yan, Ala Lisok, Mary Brummet, Martin G. Pomper, Wojciech G. Lesniak, Robert F. Dannals, Vanessa F. Merino, Babak Behnam Azad

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5731-5744

Keywords: FDOPA, PET, neuroendocrine tumors, Fluorine-18, molecular imaging

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Akihiro Ohmoto, Masami Suzuki, Erina Takai, Hirofumi Rokutan, Yuko Fujiwara, Chigusa Morizane, Kazuyoshi Yanagihara, Tatsuhiro Shibata, Shinichi Yachida

Published Sep 4, 2019 · Vol. 10, No. 52 · pp. 5494-5494

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Anna Kathrin StÃ¼ven, Bertram Wiedenmann

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3302-3311

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations Research Paper

Frank Griscelli, Christophe Desterke, Olivier Feraud, Dominique Divers, Noufissa Oudrhiri, Lucie Tosca, Ali G. Turhan, Annelise Bennaceur-Griscelli

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2693-2708

Keywords: iPSCs, genetic instability, CGH array

Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line Research Paper

Kazuyoshi Yanagihara, Takanori Kubo, Yuki Iino, Keichiro Mihara, Chie Morimoto, Toshio Seyama, Takeshi Kuwata, Atsushi Ochiai, Hiroshi Yokozaki

Published Mar 29, 2019 · Vol. 10, No. 25 · pp. 2435-2450

Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Research Paper

Lubov Borisovna Mitrofanova, Olga Mikhailovna Vorobeva, Andrey Nikolaevich Gorshkov

Published Jan 8, 2019 · Vol. 10, No. 3 · pp. 289-312

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate Research Paper

Leonidas Apostolidis, Cathleen Nientiedt, Eva Caroline Winkler, Anne Katrin Berger, Clemens Kratochwil, Annette Kaiser, Anne-Sophie Becker, Dirk JÃ¤ger, Markus Hohenfellner, Clemens HÃ¼ttenbrink, Sascha Pahernik, Florian A. Distler, Carsten GrÃ¼llich

Published Jan 1, 2019 · Vol. 10, No. 1 · pp. 17-29

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Karine Pozo, Stefan Zahler, Keisuke Ishimatsu, Angela M. Carter, Rahul Telange, Chunfeng Tan, Shuaijun Wang, Roswitha Pfragner, Junya Fujimoto, Elizabeth Gardner Grubbs, Masaya Takahashi, Sarah C. Oltmann, James A. Bibb

Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37662-37675

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib Research Paper

Paula JimÃ©nez-Fonseca, Miguel Navarro MartÃn, Alberto Carmona-Bayonas, Alfonso Calvo, Javier FernÃ¡ndez-Mateos, Miriam Redrado, Jaume Capdevila, Nieves MartÃnez Lago, Adelaida Lacasta, Javier MuÃ±arriz, Ãngel Segura, Josep Fuster, Francisco BarÃ³n, Marta Llanos, Raquel Serrano, Alfredo Castillo, Juan JesÃºs Cruz HernÃ¡ndez, Enrique Grande

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 36894-36905

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Kazuyoshi Yanagihara, Takanori Kubo, Keichiro Mihara, Takeshi Kuwata, Atsushi Ochiai, Toshio Seyama, Hiroshi Yokozaki

Published Nov 23, 2018 · Vol. 9, No. 92 · pp. 36503-36514

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

Darren S. Sigal, Munveer S. Bhangoo, Jonathan A. Hermel, Dean C. Pavlick, Garrett Frampton, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35809-35812

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells Research Paper

Shirin R. Modarai, Anindita Gupta, Lynn M. Opdenaker, Ryan Kowash, Gabriel Masters, Vignesh Viswanathan, Tao Zhang, Jeremy Z. Fields, Bruce M. Boman

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34658-34669

CCL17/TARC and CCR4 expression in Merkel cell carcinoma Research Paper

Kashif Rasheed, Ibrahim Abdulsalam, Silje Fismen, Ã˜ystein Grimstad, Baldur SveinbjÃ¸rnsson, Ugo Moens

Published Jul 31, 2018 · Vol. 9, No. 59 · pp. 31432-31447

¹⁷⁷Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors Editorial

Jonathan Strosberg

Published Jul 30, 2018 · Vol. 9, No. 69 · pp. 33059-33059

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells Research Paper

Chiara Di Stefano, Paola Grazioli, Rosaria Anna Fontanella, Paola De Cesaris, Antonella D'Amore, Michele Regno, Donatella Starace, Fabrizio Padula, Micol Elena Fiori, Rita Canipari, Antonella Stoppacciaro, Margherita Pesce, Antonio Filippini, Antonio Francesco Campese, Elio Ziparom, Anna Riccioli

Published Jul 20, 2018 · Vol. 9, No. 56 · pp. 30905-30918

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

Liqin Du, Zhenze Zhao, Milind Suraokar, Spencer S. Shelton, Xiuye Ma, Tzu-Hung Hsiao, John D. Minna, Ignacio Wistuba, Alexander Pertsemlidis

Published Jul 3, 2018 · Vol. 9, No. 51 · pp. 29601-29618

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells Correction

Ruiqi Chen, Yinan Li, Ralph Buttyan, Xuesen Dong

Published Jul 2, 2018 · Vol. 9, No. 51 · pp. 29842-29842

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study Research Paper

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases Research Paper

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations Research Paper

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations Research Paper

Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line Research Paper

Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Research Paper

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate Research Paper

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib Research Paper

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells Research Paper

CCL17/TARC and CCR4 expression in Merkel cell carcinoma Research Paper

¹⁷⁷Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors Editorial

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells Research Paper

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study Research Paper

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases Research Paper

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations Research Paper

A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations Research Paper

Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line Research Paper

Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies Research Paper

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate Research Paper

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer Research Paper

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib Research Paper

Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma Research Paper

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Research Paper

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells Research Paper

CCL17/TARC and CCR4 expression in Merkel cell carcinoma Research Paper

177Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors Editorial

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells Research Paper

LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer Research Paper

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells Correction

A side-by-side evaluation of [¹⁸F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography Research Paper

¹⁷⁷Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors Editorial